Medidata Solutions Inc (MDSO)

72.76
2.08 2.94
NASDAQ : Technology
Prev Close 70.68
Open 71.22
Day Low/High 70.89 / 73.15
52 Wk Low/High 30.22 / 54.99
Volume 456.35K
Avg Volume 452.80K
Exchange NASDAQ
Shares Outstanding 58.36M
Market Cap 4.06B
EPS 0.50
P/E Ratio 117.78
Div & Yield N.A. (N.A)

Latest News

Medytox To Further Expand Global Presence By Increasing Its Adoption Of The Medidata Clinical Cloud®

Medytox To Further Expand Global Presence By Increasing Its Adoption Of The Medidata Clinical Cloud®

Medidata (NASDAQ: MDSO), the leading global provider of cloud-based solutions and data analytics for clinical research, announced today that Medytox, a global biopharmaceutical company based in Korea, will expand its use...

Medidata's Julie Iskow Named A

Medidata's Julie Iskow Named A "Luminary" By The Healthcare Businesswomen's Association

Medidata (NASDAQ:MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, is pleased to announce that Julie Iskow has been named a 2017 "Luminary" by the Healthcare...

Medidata Introduces Regulated Content And Document Management Capabilities To Its Industry-Leading Cloud Platform

Medidata Introduces Regulated Content And Document Management Capabilities To Its Industry-Leading Cloud Platform

On the heels of its recent acquisition of CHITA, Medidata (NASDAQ:MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, today announced the availability of its...

Medidata To Present At Upcoming Investor Conferences

Medidata To Present At Upcoming Investor Conferences

Medidata (NASDAQ:MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, today announced that the company will present at the following upcoming investor conferences.

Medidata Solutions Stock Sees Short Interest Fall 13.2%

Medidata Solutions Stock Sees Short Interest Fall 13.2%

The most recent short interest data has been released for the 04/13/2017 settlement date, which shows a 695,534 share decrease in total short interest for Medidata Solutions, Inc. , to 4,569,602, a decrease of 13.21% since 03/31/2017.

Medidata Reports Record First Quarter 2017 Results

Medidata Reports Record First Quarter 2017 Results

Medidata (NASDAQ:MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, today announced its financial results for the first quarter of 2017.

UCB Selects Medidata Clinical Cloud® To Support Patient-Centric Drug Development

UCB Selects Medidata Clinical Cloud® To Support Patient-Centric Drug Development

Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions and data analytics for clinical research, today announced that UCB has selected the Medidata Clinical Cloud ® as its enterprise...

WuXi Clinical Development Services Expands Use Of Medidata's Cloud Technology Platform

WuXi Clinical Development Services Expands Use Of Medidata's Cloud Technology Platform

Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced an expanded partnership with WuXi Clinical Development Services ("WuXi CDS"), a...

Medidata To Acquire Mytrus To Take Next Step In Transforming The Clinical Trial Patient Experience

Medidata To Acquire Mytrus To Take Next Step In Transforming The Clinical Trial Patient Experience

Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions and data analytics for clinical research, today announced that the company has agreed to acquire Mytrus, Incorporated, an e-clinical technology...

Medidata Schedules First Quarter Earnings Conference Call For April 26, 2017

Medidata Schedules First Quarter Earnings Conference Call For April 26, 2017

Medidata (NASDAQ:MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, today announced that it will release its first quarter 2017 financial results before the open of the...

Medidata Wins Informa CARE Award For

Medidata Wins Informa CARE Award For "Clinical Trial Partnership Of The Year"

Medidata (NASDAQ:MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, is pleased to announce that its unique technology collaboration with TESARO, Inc.

Karyopharm And Medidata Expand Clinical Trial Partnership

Karyopharm And Medidata Expand Clinical Trial Partnership

Medidata (NASDAQ:MDSO) and clinical-stage pharmaceutical company Karyopharm Therapeutics (NASDAQ:KPTI) today announced an expanded partnership to bring novel machine-learning technology and targeted risk-based monitoring...

Medidata's Clinical Technology Platform Selected For Groundbreaking

Medidata's Clinical Technology Platform Selected For Groundbreaking "Beat AML Master Trial"

Medidata, the leading global provider of cloud-based technology and data analytics for clinical research, today announced that The Leukemia & Lymphoma Society (LLS) has selected the Medidata Clinical Cloud ® to...

Medidata And INC Research Expand Technology Partnership

Medidata And INC Research Expand Technology Partnership

INC Research Holdings, Inc. (NASDAQ:INCR), a leading, global Phase I to IV contract research organization (CRO), and Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions and data analytics...

Medidata And Medical Device Innovation Consortium Partner To Help Drive Change In The Medical Technology Space

Medidata And Medical Device Innovation Consortium Partner To Help Drive Change In The Medical Technology Space

Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions and data analytics for clinical research, today announced that the company has joined the Medical Device Innovation Consortium (MDIC), a...

Medidata To Present At Upcoming Investor Conferences

Medidata To Present At Upcoming Investor Conferences

Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced that the company will present at the following upcoming investor conferences.

Medidata Reports Record Full-Year And Fourth Quarter 2016 Results

Medidata Reports Record Full-Year And Fourth Quarter 2016 Results

Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced its financial results for the fourth quarter and full-year 2016 and provided detailed...

Medidata To Expand Its Industry-Leading Cloud Platform With Regulated Content And Document Management Capabilities

Medidata To Expand Its Industry-Leading Cloud Platform With Regulated Content And Document Management Capabilities

Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions and data analytics for clinical research, today announced that it plans to add regulated content and document management capabilities to the...

Medidata Schedules Fourth Quarter Earnings Conference Call For February 9, 2017

Medidata Schedules Fourth Quarter Earnings Conference Call For February 9, 2017

Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced that it will release its fourth quarter 2016 financial results before the open of the...

First Week of MDSO March 17th Options Trading

First Week of MDSO March 17th Options Trading

Investors in Medidata Solutions, Inc. saw new options become available this week, for the March 17th expiration.

Interesting MDSO Put And Call Options For February 17th

Interesting MDSO Put And Call Options For February 17th

Investors in Medidata Solutions, Inc. saw new options become available this week, for the February 17th expiration.

Celgene Increases Adoption Of Medidata Clinical Cloud®, Gaining Further Value From Implementation Of Medidata's Strategic Monitoring And Data Analytics Solutions

Celgene Increases Adoption Of Medidata Clinical Cloud®, Gaining Further Value From Implementation Of Medidata's Strategic Monitoring And Data Analytics Solutions

Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced that Celgene Corporation has expanded its adoption of the Medidata Clinical Cloud ®...

Medidata To Present At J.P. Morgan 35th Annual Healthcare Conference

Medidata To Present At J.P. Morgan 35th Annual Healthcare Conference

Medidata (NASDAQ: MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced that Rouven Bergmann, chief financial officer, will present at the J.

Medidata Payments Wins Scrip Award For Best Sponsor-Focused Technological Development In Clinical Trials

Medidata Payments Wins Scrip Award For Best Sponsor-Focused Technological Development In Clinical Trials

Medidata (NASDAQ:MDSO) is pleased to announce that its global site payment technology, Medidata Payments, was recognized as the 2016 "Best Technological Development in Clinical Trials - Sponsor Focused" by SCRIP...

Medidata To Present At Piper Jaffray Healthcare Conference

Medidata To Present At Piper Jaffray Healthcare Conference

Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced that Rouven Bergmann, chief financial officer, will present at the 28 th Annual...

Medidata Introduces EConnect Partner Program

Medidata Introduces EConnect Partner Program

Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions and data analytics for clinical research, today announced the launch of the Medidata eConnect Partner Program.

Medidata Honors Chiltern With Inaugural Architect Of Hope Award, Celebrating Innovation In Life Sciences

Medidata Honors Chiltern With Inaugural Architect Of Hope Award, Celebrating Innovation In Life Sciences

Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, is pleased to announce that Chiltern, a leading global contract research organization (CRO), is one of...

French Biopharma Invests In Medidata Technology To Drive Cutting-Edge Cancer And Rare Disease Research

French Biopharma Invests In Medidata Technology To Drive Cutting-Edge Cancer And Rare Disease Research

Medidata (NASDAQ: MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced that Erytech Pharma ("Erytech"), a French biopharmaceutical company developing...